This study showed that the median time to onset of the overall GLP-1 RA-related AEs was 31 days (IQR = 7145.4 days), which varied among GLP-1 RA regimens
GLP-1 receptor agonists are medications commonly prescribed to help manage type 2 diabetes and, in some cases, support medically supervised weight management
Patients who gained weight or maintained their weight while on a GLP-1 medication were most likely to experience weight loss after switching to phentermine with a median weight loss of around 3% in the year after discontinuing the GLP-1 medication
For statin intolerance, NICE recommends alternatives including ezetimibe, bempedoic acid, and PCSK9 inhibitors based on cardiovascular risk and LDL-C targets
This synthetic peptide allows users to achieve the desired tan even with limited sun exposure, making it a popular option for those who prefer a quicker, safer way to tan
I am taking a GLP-1 weight-loss medicationWhat should I know